ALLMedicine™ Digestive Disease Center

Aug 2nd, 2022 - This is a double-blinded, parallel (1:1) group, randomized-controlled, superiority trial. Patients will be blinded to their treatment allocation and will understand that by entering the study, they may receive diagnostic laparoscopy only in which ...

Aug 1st, 2022 - Common variable immunodeficiency (CVID) is the most common symptomatic humoral deficiency in adults and is accompanied by digestive symptoms. It is associated with intestinal dysbiosis and half of the patients exert a clinical digestive disease, c...

Jul 21st, 2022 - To investigate the safety, efficiency and cost of total joint arthroplasty (TJA) under the enhanced recovery after surgery (ERAS) program and identify predictors facilitating further decrease in length of stay (LOS). We retrospectively collected t...

Jul 19th, 2022 - Esophageal cancer is the sixth most common cause of cancer death worldwide, killing over 380,000 people each year. Over 80% of esophageal cancers occur in developing countries, where the great majority of cases are squamous cell carcinomas. Esopha...

Jul 1st, 2022 - Digestive Disease Week 2022.|2022|Hindson J,|therapy,therapy,

Aug 2nd, 2022 - This is a double-blinded, parallel (1:1) group, randomized-controlled, superiority trial. Patients will be blinded to their treatment allocation and will understand that by entering the study, they may receive diagnostic laparoscopy only in which ...

Aug 1st, 2022 - Common variable immunodeficiency (CVID) is the most common symptomatic humoral deficiency in adults and is accompanied by digestive symptoms. It is associated with intestinal dysbiosis and half of the patients exert a clinical digestive disease, c...

Jul 19th, 2022 - Esophageal cancer is the sixth most common cause of cancer death worldwide, killing over 380,000 people each year. Over 80% of esophageal cancers occur in developing countries, where the great majority of cases are squamous cell carcinomas. Esopha...

Apr 14th, 2022 - This is an explorative, prospective, monocentric open-label study qualified as interventional researches at minimal risks and constraints (called in French RIPH, category 2). This is a study of the gut microbiota and its characteristics in ScS pat...

Jan 4th, 2022 - This study is a multi-center cross-sectional survey and diagnostic test led by the National Clinical Research Center for Digestive Disease (Shanghai) (Department of Gastroenterology, Changhai Hospital, Naval Medical University), which is conducted...

Jul 19th, 2022 - In a novel analysis accounting for protopathic bias, proton pump inhibitor (PPI) therapy was not associated with increased risk for death due to digestive disease, cancer, cardiovascular disease (CVD), or any cause, although the jury is out on ren...

Jul 14th, 2022 - This transcript has been edited for clarity. Hi. I'm Dr Vivek Kaul and I'm professor of medicine in the Division of Gastroenterology & Hepatology at the University of Rochester Medical Center. It gives me great pleasure to do this presentation in ...

Jun 8th, 2022 - This transcript has been edited for clarity. Hello. I'm Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia. I've just returned back from San Diego, where Digestive Disease ...

Jun 7th, 2022 - A new artificial intelligence (AI) system can help expert endoscopists improve their colonoscopies, a new study indicates. Endoscopists using the computer program SKOUT (Iterative Scopes, Inc) achieved a 27% better detection rate of adenomas per c...

Jun 2nd, 2022 - Sorry, cat people and only children: Having a dog as a toddler and growing up in a large family are two things linked to a significantly lower chance of getting Crohn's disease later in life, according to a new study. Children who lived with a dog...